Acapatamab - Research Grade Biosimilar

CAT:
223-21-881
Size:
0.1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Acapatamab - Research Grade Biosimilar - image 1

Acapatamab - Research Grade Biosimilar

  • NCBI Gene ID:

    916
  • Swiss Prot:

    P07766
  • Accession Number:

    P07766
  • Immunogen:

    Chimeric, Humanized / FOLH1, CD3E
  • Clonality:

    Recombinant Monoclonal
  • Conjugation:

    Unconjugated
  • Type:

    Primary Antibodies, Biosimilars
  • Source:

    CHO cells
  • Field of Research:

    Other
  • Purification:

    >95%
  • Concentration:

    Batch dependent
  • Purity:

    >95%
  • Buffer:

    PBS buffer pH 7.5
  • Modification:

    None
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks) . Store at -20 °C 12 months. Store at -80°C long term.
  • Fragment:

    Bispecific scFv; Kappa; Lambda
  • Symbol:

    CD3E
  • NCBI Official Name:

    CD3 epsilon subunit of T-cell receptor complex
  • NCBI Organism:

    Homo sapiens
  • Other Product Names:

    ACAPATAMAB , ACAPATAMAB [INN] , MMUNOGLOBULIN SCFV-SCFV-SCFC, ANTI- (HOMO SAPIENS FOLH1 (FOLATE HYDROLASE, PROSTATE SPECIFIC MEMBRANE ANTIGEN, PSMA) ) AND ANTI- (HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4) ), MONOCLONAL ANTIBODY SINGLE CHAIN (SCFV) 2-SCFC, BISPECIFIC, T3E; TCRE; IMD18; CD3epsilon
  • CAS Number:

    2314491-93-3